错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Intra-tumoral T cells in pediatric brain tumors display clonal expansion and effector properties

  • Aditi Upadhye,
  • Kevin E. Meza Landeros,
  • Ciro Ramírez-Suástegui,
  • Benjamin J. Schmiedel,
  • Edwin Woo,
  • Serena J. Chee,
  • Denise Malicki,
  • Nicole G. Coufal,
  • David Gonda,
  • Michael L. Levy,
  • Jason A. Greenbaum,
  • Grégory Seumois,
  • John Crawford,
  • William D. Roberts,
  • Stephen P. Schoenberger,
  • Hilde Cheroutre,
  • Christian H. Ottensmeier,
  • Pandurangan Vijayanand,
  • Anusha-Preethi Ganesan

摘要

Brain tumors in children are a devastating disease in a high proportion of patients. Owing to inconsistent results in clinical trials in unstratified patients, the role of immunotherapy remains unclear. We performed an in-depth survey of the single-cell transcriptomes and clonal relationship of intra-tumoral T cells from children with brain tumors. Our results demonstrate that a large fraction of T cells in the tumor tissue are clonally expanded with the potential to recognize tumor antigens. Such clonally expanded T cells display enrichment of transcripts linked to effector function, tissue residency, immune checkpoints and signatures of neoantigen-specific T cells and immunotherapy response. We identify neoantigens in pediatric brain tumors and show that neoantigen-specific T cell gene signatures are linked to better survival outcomes. Notably, among the patients in our cohort, we observe substantial heterogeneity in the degree of clonal expansion and magnitude of T cell response. Our findings suggest that characterization of intra-tumoral T cell responses may enable selection of patients for immunotherapy, an approach that requires prospective validation in clinical trials.